The article's
lead section may need to be rewritten. (November 2021) |
Jennifer E. Van Eyk | |
---|---|
Born | Northern Ontario, Canada |
Alma mater | University of Alberta |
Scientific career | |
Institutions | Cedars-Sinai |
Thesis | Peptide chemistry answers questions in muscle regulation (1991) |
Doctoral advisor | Robert S. Hodges |
Jennifer Eileen Van Eyk is the Erika Glazer Chair in Women's Heart Health, the Director of Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences, the Director of Basic Science Research in the Women's Heart Center, a Professor in Medicine and in Biomedical Sciences at Cedars-Sinai. [1] She is a renowned scientist in the field of clinical proteomics.
Jennifer E. Van Eyk was born in Northern Ontario, Canada. [2] She obtained a bachelor of science in biology and chemistry from the University of Waterloo in 1982. [3] She received a PhD in biochemistry under the direction of Robert S. Hodges from University of Alberta in 1991. [4] She conducted post-doctoral research at University of Heidelberg, University of Alberta, and University of Illinois at Chicago with R. John Solaro. [1]
Van Eyk began her academic career in 1996 as an assistant professor in the Department of Physiology at Queen's University, Kingston, Canada, and she was promoted to associate professor and received tenure in 2001. [3] [5] She then left Canada to join Johns Hopkins University as the Director of the Proteomics Innovation Center in Heart Failure in 2003, and later Cedars-Sinai in 2014. [1] [5] [2]
Van Eyk is a member-at-large and a council member of Human Proteome Organization, [6] and the president of US Human Proteome Organization. [7] She was a technical briefs editor at Proteomics. [8] She served on the editorial board of Proteomics: clinical application and Journal of Physiology and Circulation Research. [9] She currently serves on the editorial board of Clinical Proteomics. [10] She is a Fellow of the International Society for Heart Research. [11] and is a Fellow of the American Heart Association.
She is an international leading scientist in clinical proteomics. [12] She is the founding director of Cedars-Sinai Advanced Clinical Biosystems Research Institute, [13] whose motto is “from discovery to patient care”. [14]
She is co-editor of Clinical Proteomics: From Diagnosis to Therapy, [15] an essential, important and impressive book in clinical proteomics and translational medicine. [16]
Her list of publications: https://www.ncbi.nlm.nih.gov/sites/myncbi/1VsYqQYH8535l/bibliography/48183272/public/.
{{
cite book}}
: CS1 maint: others (
link)
This article needs additional or more specific
categories. (November 2021) |
The article's
lead section may need to be rewritten. (November 2021) |
Jennifer E. Van Eyk | |
---|---|
Born | Northern Ontario, Canada |
Alma mater | University of Alberta |
Scientific career | |
Institutions | Cedars-Sinai |
Thesis | Peptide chemistry answers questions in muscle regulation (1991) |
Doctoral advisor | Robert S. Hodges |
Jennifer Eileen Van Eyk is the Erika Glazer Chair in Women's Heart Health, the Director of Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences, the Director of Basic Science Research in the Women's Heart Center, a Professor in Medicine and in Biomedical Sciences at Cedars-Sinai. [1] She is a renowned scientist in the field of clinical proteomics.
Jennifer E. Van Eyk was born in Northern Ontario, Canada. [2] She obtained a bachelor of science in biology and chemistry from the University of Waterloo in 1982. [3] She received a PhD in biochemistry under the direction of Robert S. Hodges from University of Alberta in 1991. [4] She conducted post-doctoral research at University of Heidelberg, University of Alberta, and University of Illinois at Chicago with R. John Solaro. [1]
Van Eyk began her academic career in 1996 as an assistant professor in the Department of Physiology at Queen's University, Kingston, Canada, and she was promoted to associate professor and received tenure in 2001. [3] [5] She then left Canada to join Johns Hopkins University as the Director of the Proteomics Innovation Center in Heart Failure in 2003, and later Cedars-Sinai in 2014. [1] [5] [2]
Van Eyk is a member-at-large and a council member of Human Proteome Organization, [6] and the president of US Human Proteome Organization. [7] She was a technical briefs editor at Proteomics. [8] She served on the editorial board of Proteomics: clinical application and Journal of Physiology and Circulation Research. [9] She currently serves on the editorial board of Clinical Proteomics. [10] She is a Fellow of the International Society for Heart Research. [11] and is a Fellow of the American Heart Association.
She is an international leading scientist in clinical proteomics. [12] She is the founding director of Cedars-Sinai Advanced Clinical Biosystems Research Institute, [13] whose motto is “from discovery to patient care”. [14]
She is co-editor of Clinical Proteomics: From Diagnosis to Therapy, [15] an essential, important and impressive book in clinical proteomics and translational medicine. [16]
Her list of publications: https://www.ncbi.nlm.nih.gov/sites/myncbi/1VsYqQYH8535l/bibliography/48183272/public/.
{{
cite book}}
: CS1 maint: others (
link)
This article needs additional or more specific
categories. (November 2021) |